Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study

Journal of Clinical and Experimental Neuropsychology

Volumn 34, Issue 5, 2012, Pages 543-560

  Scherling, Carole ^a   Collins, Barbara ^b   MacKenzie, Joyce ^b   Bielajew, Catherine ^a   Smith, Andra ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Breast cancer; Chemotherapy; Functional magnetic resonance imaging; Pretreatment cognitive impairment; Response inhibition

Indexed keywords

HEMOGLOBIN; HYDROCORTISONE; OXYGEN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD; BRAIN; BREAST TUMOR; CIRCADIAN RHYTHM; DECISION MAKING; FEMALE; HUMAN; IMAGE PROCESSING; INHIBITION (PSYCHOLOGY); LEUKOCYTE; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; VASCULARIZATION;

ADULT; AREA UNDER CURVE; BRAIN; BREAST NEOPLASMS; CIRCADIAN RHYTHM; DECISION MAKING; FEMALE; HEMOGLOBINS; HUMANS; HYDROCORTISONE; IMAGE PROCESSING, COMPUTER-ASSISTED; INHIBITION (PSYCHOLOGY); LEUKOCYTES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NEUTROPHILS; OXYGEN; REGRESSION ANALYSIS;

EID: 84860489345     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803395.2012.666227     Document Type: Article

References (97)

1. Abercrombie, H. C., Giese-Davis, J., Sephton, S., Epel, E. S., Turner-Cobb, J. M., & Spiegel, D. (2004). Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology, 29, 1082-1092.
2. Abraham, J., Haut, M. W., Moran, M. T., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008). Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging. Clinical Breast Cancer, 8(1), 88-91.
3. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
4. Ahles, T. A., Tope, D. M., Furstenberg, C., Hann, D., & Mills, L. (1996). Psychologic and neuropsychologic impact of autologous bone marrow transplantation. Journal of Clinical Oncology, 14, 1457-1462.
5. Baddeley, A. (1998). Working memory. Comptes Rendus de l'Académie des Sciences. Série III, Sciences de la Vie, 321, 167-173.
6. Baudino, B., D'Agata, F., Castellano, G., Caroppo, P., Cauda, S., Parente, A., et al. (in press). Chemotherapy effects on brain glucose metabolism at rest. Nature Precedings. Retrieved from http://hdl. handle.net/10101/npre. 2011.5637.1
7. Beck, A. T., & Steer, R. A. (1990). Beck Anxiety Inventory manual. San Antonio, TX: Psychological Corporation.
8. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory-Second Edition manual. San Antonio, TX: Psychological Corporation.
9. Behl, C. (2002). Oestrogen as a neuroprotective hormone. National Review of Neuroscience, 3(6), 433-442.
10. Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufksy, A. M., Paraska, K. K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-oncology, 15, 422-430.
11. Berglund, G., Bolund, C., Fornander, T., Rutqvist, L. E., & Sjoden, P. (1991). Late effects of adjuvant chemotherapy on quality of life among breast cancer patients. European Journal of Cancer, 27, 1075-1081.
12. Berlin, H. A., Rolls, E. T., & Iversen, S. D. (2005). Borderline personality disorder, impulsivity, and the orbitofrontal cortex. American Journal of Psychiatry, 162, 2360-2373.
13. Bremner, J. D., Southwick, S. M., & Charney, D. S. (1999). The neurobiology of posttraumatic stress disorder: An integration of animal and human research. Posttraumatic stress disorder: A comprehensive text (pp. 103-143). New York, NY: Allyn & Bacon.
14. Brezden, C., Phillips, K. A., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.
15. Brown, M. S., Stemmer, S. M., Simon, J. H., Stears, J. C., Jones, R. B., Cagnoni, P. J., et al. (1998). White matter disease induced by high-dose chemotherapy: Longitudinal study with MR imaging and proton spectroscopy. American Journal of Neuroradiology, 19(2), 217-221.
16. Bunge, S. A., Dudukovic, N. M., Thomason, M. E., Vaidya, C. J., & Gabrieli, J. D. E. (2002). Immature frontal lobe contributions to cognitive control in children: Evidence from fMRI. Neuron, 33, 301-311.
17. Cabeza, R., Mangels, J., Nyberg, L., Habib, R., Houle, S.,McIntosh, A. R., et al. (1997). Brain regions differentially involved in remembering what and when: A PET study. Neuron, 19, 863-870.
18. Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26, 955-969.
19. Chen, A. C. H., Porjesz, B., Rangaswamy, M., Kamarajan, C., Tang, Y., Jones, K. A., et al. (2007). Reduced frontal lobe activity in subjects with high impulsivity and alcoholism. Alcoholism: Clinical and Experimental Research, 31(1), 156-165.
20. Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., et al. (2010). Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology, 32(3), 324-331.
21. CNS Vital Signs. (2012). Retrieved from http://www. cnsvs.com
22. Correa, D. D., & Ahles, T. A. (2007). Cognitive adverse effects of chemotherapy in breast cancer patients. Current Opinion in Supportive and Palliative Care, 1(1), 57-62.
23. Demaree, H. A., Gaudino, E. A., DeLuca, J., & Ricker, J. H. (2000). Learning impairment is associated with recall ability in multiple sclerosis. Journal of Clinical and Experimental Neuropsychology, 22, 865-873.
24. Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2010). Chemotherapyinduced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human Brain Mapping, 32(3), 480-493.
25. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S., Nederveen, A. J., et al. (2010). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32(8), 1206-1219.
26. Dijkstra, J. B., Houx, P. J., & Jolles, J. (1999). Cognition after major surgery in the elderly: Test performance and complaints. British Journal of Anaesthesia, 82, 867-874.
27. Dodds, C., & Allison, J. (1998). Postoperative cognitive deficit in the elderly surgical patient. British Journal of Anaesthesia, 81, 449-462.
28. Ferguson, R. J.,McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007). Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. Journal of Clinical Oncology, 25, 3866-3870.
29. Friston, K. J., Ashburner, J., Poline, J. B., Frith, C. D., Heather, J. D., & Frackowiak, R. S. J. (1995). Spatial realignment and normalization of images. Human Brain Mapping, 2, 165-189.
30. Garavan, H., Ross, T. J., Kaufman, J., & Stein, E. A. (2003). A midline dissociation between errorprocessing and response-conflict monitoring. NeuroImage, 20, 1132-1139.
31. 215O PET study of the Stroop and an emotional Stroop. Human Brain Mapping, 1, 194-209.
32. Gottschalk, L. A., Holcombe, R. F., Jackson, D., & Bechtel, R. J. (2003). The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. Methods & Findings in Experimental and Clinical Pharmacology, 25, 117-122.
33. Greenstein, B., & Greenstein, A. (2000). The cingulate gyrus. Color atlas of neuroscience: Neuroanatomy and neurophysiology (pp. 326-327). New York, NY: Thieme.
34. Gualtieri, C. T., & Johnson, L. G. (2006). Reliability and validity of a computerized neurocognitive test battery, CNS vital signs. Archives of Clinical Neuropsychology, 21(7), 623-643.
35. Hurria, A., Rosen, C., Hudis, C., Zuckerman, E., Panageas, K. S., Lachs, M. S., et al. (2006). Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study. Journal of the American Geriatrics Society, 54, 925-931.
36. Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., et al. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109, 146-156.
37. Jenkins, V., Shilling, V., Deutsch, G., Bloomfield, D., Morris, R., Allan, S., et al. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94, 828-834.
38. Kesler, S. R., Bennett, F. C., Mahaffey, M. L., & Spiegel, D. (2009). Regional brain activation during verbal declarative memory in metastatic breast cancer. Clinical Cancer Research, 15(21), 6665-6673.
39. Kirschbaum, C., & Hellhammer, D. H. (1994). Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology, 19(4), 313-333.
40. Krampen, G. (1991). Fragebogen zu Kompetenz-und Kontrollueberzeugungen (FKK) [Inventory for the measurement of self-efficacy and externality]. Göttingen, Germany: Hogrefe.
41. Kreukels, B. P., Hamburger, H. L., de Ruiter, M. B., van Dam, F. S., Ridderinkhof, K. R., Boogerd, W., et al. (2008). ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clinical Neurophysiology, 119(3), 533-541.
42. Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Hamburger, H. L., Muller, M. J., et al. (2006). Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: An electrophysiologic study. Clinical Breast Cancer, 7(1), 67-78.
43. Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Hamburger, H. L., & van Dam, F. S. (2005). Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Research and Treatment, 94(1), 53-61.
44. Kumari, M., Badrick, E., Chandola, T., Adler, N. E., Epel, E., & Seeman, T. (2010). Measures of social position and cortisol secretion in an aging population: Findings from the Whitehall II study. Psychosomatic Medicine, 72(1), 27-34.
45. Lepsien, J., & Pollmann, S. (2002). Covert reorienting and inhibition of return: An event related fMRI study. Journal of Cognitive Neuroscience, 14, 127-144.
46. Li, C. S. R, Yan, P., Sinha, R., & Lee, T. W. (2008). Subcortical processes of motor response inhibition during a stop signal task. NeuroImage, 41, 1352-1363.
47. Lord, C., Buss, C., Lupien, S. J., & Pruessner, J. C. (2008). Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect. Neurobiology of Aging, 29(1), 95-101.
48. Luna, B., Thulborn, K. R., Munoz, D. P., Merriam, E. P., Garver, K. E., Minshew, N. J., et al. (2001). Maturation of widely distributed brain function subserves cognitive development. NeuroImage, 13, 786-793.
49. Lupien, S. J. (2002). The neuroendocrinology of cognitive disorders. In H. D'haenen, J. A. den Boer,& P. Willner (Eds.), Textbook of biological psychiatry (pp. 273-282). Chichester, UK: John Wiley & Sons.
50. Lupien, S. J., Gillin, C. J., & Hauger, R. L. (1999). Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: A doseresponse study in humans. Behavioral Neuroscience, 113, 420-430.
51. Maier, S. F., &Watkins, L. R. (2003). Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment. Brain, Behavior, and Immunity, 17, 125-131.
52. Mainero, C., Caramia, F., Pozzilli, C., Pisani, A., Pestalozza, I., Borriello, G., et al. (2004). fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. NeuroImage, 21, 858-867.
53. Mar Fan, H. G., Houédé-Tchen, N., Yi, Q. L., Chemerynsky, I., Downie, F. P., Sabate, K., et al. (2005). Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1-and 2-year follow-up of a prospective controlled study. Journal of Clinical Oncology, 31, 8025-8032.
54. Mayer, A. R., Harrington, D. L., Stephen, J., Adair, J. C., & Lee, R. R. (2007). An event related fMRI study of exogenous facilitation and inhibition of return in the auditory modality. Journal of Cognitive Neuroscience, 19(3), 455-467.
55. McDonald, B. C., Conroy, S. K., Ahles, T. A.,West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Research and Treatment, 123(3), 819-828.
56. McEwen, B. S. (1999). Stress and the aging hippocampus. Frontiers in Neuroendocrinology, 20, 49-70.
57. McEwen, B. (2002). Estrogen actions throughout the brain. Recent Progress in Hormone Research, 57, 357-384.
58. McEwen, B. S., & Magarinos,M. (1997). Stress effects on morphology and function of the hippocampus. Annals of the New York Academy of Sciences, 821, 271-284.
59. Middleton, F. A.,&Strick, P. L. (2000). Basal ganglia and cerebellar loops: Motor and cognitive circuits. Brain Research Reviews, 31, 236-250.
60. Monk, T. G., Weldon, B. C., Garvan, C. W., Dede, D. E., van der Aa, M. T., Heilman, K. M., et al. (2008). Predictors of cognitive dysfunction aftermajor noncardiac surgery. Anesthesiology, 108(1), 18-30.
61. Noal, S., Levy, C., Hardouin, A., Rieux, C., Heutte, N., Ségura, C., et al. (2011). One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 81(3), 795-803.
62. Pruessner, J. C., Baldwin, M. W., Dedovic, K., Renwick, R.,Mahani, N. K., Lord, C., et al. (2005). Self-esteem, locus of control, hippocampal volume, and cortisol regulation in young and old adulthood. NeuroImage, 28(4), 815-826.
63. Pruessner, J. C., Kirschbaum, C., Meinlschmid, G., & Hellhammer, D. H. (2003). Two formulas for the computation of the area under the curve represent measures of total hormone concentration versus timedependent change. Psychoneuroendocrinology, 28(7), 916-931.
64. Raffa, R. B., & Tallarida, R. J. (2010). Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced "chemofog". Journal of Clinical Pharmacy and Therapeutics, 35(3), 249-255.
65. Reid-Arndt, S. A., Hsieh, C., & Perry, M. C. (2010). Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psycho-oncology, 19, 535-544.
66. Rosenberg, M. (1985). Self-concept and psychological well-being in adolescence. In R. L. Leahy (Ed.), The development of the self (pp. 205-246). Orlando, FL: The Academic Press.
67. Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S. C. R, Simmons, A., et al. (2000). Functional frontalisation with age: Mapping neurodevelopmental trajectories with fMRI. Neuroscience & Biobehavioral Reviews, 24, 13-19.
68. Rubia, K., Russell, T., Bullmore, E. T., Soni, W., Brammer, M. J., Simmons, A., et al. (2001). An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophrenia Research, 52, 47-55.
69. Rubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2003). Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. NeuroImage, 20, 351-358.
70. Rubia, K., Smith, A. B, Taylor, E., & Brammer, M. (2007). Linear age-correlated functional development of right inferior fronto-striato- cerebellar networks during response inhibition and anterior cingulate during error-related processes. Human BrainMapping, 28, 1163-1177.
71. Rubia, K., Smith, A. B., Woolley, J., Nosarti, C., Heyman, I., Taylor, E., et al. (2006). Progressive increase of fronto-striatal brain activation from childhood to adulthood during event related tasks of cognitive control. Human Brain Mapping, 27, 973-993.
72. Sapolsky, R. (1985). A possible mechanism for glucocorticoid toxicity in the hippocampus: Increased vulnerability of neurons to metabolic insults. Journal of Neuroscience, 5, 1228-1232.
73. Saykin, A. J., Ahles, T. A., & Schoenfeld, J. D. (2003). Gray matter reduction on voxel based morphometry in chemotherapy-treated cancer survivors. Journal of the International Neuropsychological Society, 9, 246.
74. Saykin, A. J., McDonald, B. C., Ahles, T., Chesnut, L. A., Wang, P. J., Furstenberg, C. T., et al. (2006). Altered brain activation following systemic chemotherapy for breast cancer: Interim analysis from a prospective fMRI study. Abstract presented at 34th Annual Meeting of the International Neuropsychological Society, Boston, MA, February 2006.
75. Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., et al. (2002). Late effects of adjuvant chemotherapy on cognitive function: A follow-up study in breast cancer patients. Annals of Oncology, 132, 1387-1397.
76. Schagen, S. B., van Dam, F., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640-650.
77. Scherling, C., Collins, B., MacKenzie, J., Bielajew, C., & Smith, A. (2011). Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: An fMRI study. Frontiers in Human Neuroscience, 5, 122.
78. Scherwath, A.,Mehnart, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., et al. (2006). Neuropsychological function in high-risk breast cancer survivors after stem-cell supported highdose therapy versus standard-dose chemotherapy: Evaluation of long-term treatment effects. Annals of Oncology, 17, 415-423.
79. Servaes, P., Verhagen, C., & Bleijenberg, G. (2002). Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: Daily self-report and objective behavior. Cancer, 95, 2017-2026.
80. Shilling, V., & Jenkins, V. (2007). Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing, 11, 6-15.
81. Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005). The effects of adjuvant chemotherapy on cognition in women with breast cancer-Preliminary results of an observational longitudinal study. Breast, 14, 142-150.
82. Shughrue, P. J., & Merchenthaler, I. (2000). Estrogen is more than just a "sex hormone": Novel sites for estrogen action in the hippocampus and cerebral cortex. Frontiers in Neuroendocrinology, 21(1), 95-101.
83. Silverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., et al. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103, 303-311.
84. Smith, A. M., Fried, P. A., Hogan, M. J., & Cameron, I. (2004). Effects of prenatal marijuana on response inhibition: An fMRI study of young adults. Neurotoxicology and Teratology, 26, 533-542.
85. Spiegel, D., Giese-Davis, J., Taylor, C. B., & Kraemer, H. (2006). Stress sensitivity in metastatic breast cancer: Analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology, 31, 1231-1244.
86. Staffen, W., Mair, A., Zauner, H., Unterrainer, J., Niederhofer, H., Kutzelnigg, A., et al. (2002). Cognitive function and fMRI in patients with multiple sclerosis: Evidence for compensatory cortical activation during an attention task. Brain, 125(6), 1275-1282.
87. Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992). Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biological Psychiatry, 32, 756-765.
88. Stewart, A., Collins, B., MacKenzie, J., Tomiak, E., Verma, S., & Bielajew, C. (2007). The cognitive effects of adjuvant chemotherapy in early stage breast cancer: A prospective study. Psycho-oncology, 17, 1-9.
89. Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q. L., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21, 4175-4183.
90. Tuxen, M. K., & Werner, H. S. (1994). Neurotoxicity secondary to antineoplastic drugs. Cancer Treatment Reviews, 20, 191-214.
91. van Dam, F., Schagen, S. B., Muller, M. J., Boogerd, W., van der Wall, E., Droogleever Fortuyn, M. E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for highrisk breast cancer: High-dose versus standarddose chemotherapy. Journal of the National Cancer Institution, 90, 210-218.
92. Vardy, J., Booth, C., Pond, G. R., Zhang, H., Galica, J., Dhillon, H., et al. (2007). Cytokine levels in patients with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function. Abstract presented at the American Society of Clinical Oncology-Poster, Patient and Survivor Care, Chicago, IL, June 2007. Abstract no. 9070.
93. Wagner, L. I., Sweet, J. J., Butt, Z., Desai, J., Beaumont, J., Havlin, K. A., et al. (2006). Cognitive impairment associated with chemotherapy for breast cancer: An exploratory case-control study. Abstract presented at American Society of Clinical Oncology-Clinical Science Symposium, Cognitive Impairment in Cancer Survivors, Atlanta, GA, June 2006. Abstract no. 8501.
94. Wechsler, D. (1997). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio, TX: Harcourt, Brace, & Co.
95. Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer, 100, 2292-2299.
96. Wieneke, M. H., & Dienst, E. R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology, 4, 61-66.
97. Zheng, D., Oka, T., Bokura, H., & Yamaguchi, S. (2008). The key locus of common response inhibition network for no-go and stop signals. Journal of Cognitive Neuroscience, 20(8), 1-9.